Latest filing published 16 Oct 2025 for Sutro Biopharma, INC., €34k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +1.9%Entry US$10.10 · Close 22 Oct 2026 US$10.29
- -1.5%Entry US$3,207.60 · Close at T+365 US$3,159.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Connie Matsui: trading record in brief
Connie Matsui (senior executive) discloses dealings in 4 companies, chiefly Biogen Inc., Halozyme Therapeutics, Inc. and Artelo Biosciences, Inc. In total, 87 filings cover trades dated from 18 May 2004 to 15 October 2025.
The open-market side counts 2 purchases for €80k alongside 45 sales for €13.5M. The net balance comes to €13.4M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 22 share grants and 12 option exercises. Since January 2025: 1 purchase and no sales on the market.
The latest filing, published on 16 October 2025, reports an open-market purchase of €34k in Sutro Biopharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Connie Matsui
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares@ US$0.799100.0% of flowCommon StockSEC:0001236537-25-000006:0Canonical exit: 13 Jan 2026 (T+90)
- 10,470 shares0Common StockSEC:0001415889-24-028062:0
- 6,501 shares0Common StockSEC:0001415889-24-011698:0
- 8,065 shares0Common StockSEC:0001415889-23-007692:0
- 9,250 shares0Common StockSEC:0001415889-22-011512:0
- 6,206 shares0Restricted Stock UnitsSEC:0001179110-22-002910:0
- 12,548 shares@ US$40.7722.8% of flowCommon StockSEC:0001179110-21-009910:1
- 19,452 shares@ US$40.126100.0% of flowCommon StockSEC:0001179110-21-009910:0
- 5,230 shares0Restricted Stock UnitsSEC:0001179110-21-004973:0
- 32,000 shares@ US$27.0652.0% of flowCommon StockSEC:0001179110-20-009727:0
- 8,000 shares0Common StockSEC:0001179110-20-009727:1
- 41,667 shares@ US$1.20100.0% of flowCommon StockSEC:0001640334-20-001029:0Canonical exit: 2 Aug 2020 (T+90)
- 8,829 shares0Common StockSEC:0001179110-20-005380:0
- 12,173 shares0Common StockSEC:0001179110-19-005508:0
- 15,000 shares0Common StockSEC:0001179110-18-013625:0
- 10,363 shares0Common StockSEC:0001179110-18-006090:0
- 15,000 shares0Common StockSEC:0001179110-17-012575:0
- 10,000 shares@ US$10.376.3% of flowCommon StockSEC:0001179110-17-006946:0
- 14,135 shares0Common StockSEC:0001179110-17-006701:0
- 20,202 shares0Common StockSEC:0001179110-16-024080:0
- 10,000 shares@ US$2.33Common StockSEC:0001104659-15-065257:0
- 10,000 shares@ US$4.94Common StockSEC:0001104659-15-065257:1
- 13,175 shares0Common StockSEC:0001159036-15-000055:0
- 24,876 shares0Common StockSEC:0001159036-14-000055:0
- 20,000 shares0Common StockSEC:0001483813-13-000058:0
25 of 74 declarations
